Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study
2003 ◽
Vol 14
(11)
◽
pp. 1079-1088
◽
Keyword(s):
Phase I
◽